Donor―recipient allele-level HLA matching of unrelated cord blood units reveals high degrees of mismatch and alters graft selection

The feasibility of selecting cord blood (CB) units at high-resolution HLA match has not been investigated. We analyzed the high-resolution donor-recipient HLA match of 100 double-unit 4-6/6 HLA-A,-B antigen, -DRB1 allele-matched CB grafts (units 1a and 1b) and their back-up units (n=377 units in tot...

Full description

Saved in:
Bibliographic Details
Published inBone marrow transplantation (Basingstoke) Vol. 49; no. 9; pp. 1184 - 1186
Main Authors DAHI, P. B, PONCE, D. M, KERNAN, N. A, SCARADAVOU, A, BARKER, J. N, DEVLIN, S, EVANS, K. L, LUBIN, M, GONZALES, A. M, BYAM, C, SIDEROFF, M, WELLS, D, GIRALT, S
Format Journal Article
LanguageEnglish
Published Basingstoke Nature Publishing Group 01.09.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The feasibility of selecting cord blood (CB) units at high-resolution HLA match has not been investigated. We analyzed the high-resolution donor-recipient HLA match of 100 double-unit 4-6/6 HLA-A,-B antigen, -DRB1 allele-matched CB grafts (units 1a and 1b) and their back-up units (n=377 units in total). The median cryopreserved graft dose was 2.9 × 10(7)/kg/unit, and at high resolution these units had a median donor-recipient HLA-allele match of 5/8 (range 2-8/8) and 6/10 (range 2-9/10), respectively. We then evaluated how often use of high-resolution HLA-match criteria would change the original graft selection to substitute one or both of the back-up units for units 1a and/or 1b. On using a model in which both a higher eight-allele HLA match and a cell dose ⩾ 2.0 × 10(7)/kg/unit were required, graft selection changed in 33% of transplants with minimal effect on cell dose (8.3% reduction). In summary, while units chosen based on HLA-A,-B antigen and -DRB1 allele match have substantial mismatch at higher resolution, CB selection based on high-resolution HLA match is possible in a significant proportion of patients without compromise in cell dose.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0268-3369
1476-5365
DOI:10.1038/bmt.2014.135